Introduction:Basic information about CAS 1453-82-3|Isonicotinamide, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Isonicotinamide is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
Related Catalog
Research Areas >>OthersSignaling Pathways >>Others >>Others
Chemical & Physical Properties
Density
1.2±0.1 g/cm3
Boiling Point
334.4±15.0 °C at 760 mmHg
Melting Point
155-157 °C(lit.)
Molecular Formula
C6H6N2O
Molecular Weight
122.13
Flash Point
156.0±20.4 °C
Exact Mass
122.048012
PSA
55.98000
LogP
-0.28
Vapour Pressure
0.0±0.7 mmHg at 25°C
Index of Refraction
1.570
InChIKey
VFQXVTODMYMSMJ-UHFFFAOYSA-N
SMILES
NC(=O)c1ccncc1
Water Solubility
191.7 g/L (37 ºC)
Toxicological Information
CHEMICAL IDENTIFICATION
RTECS NUMBER :
NR9500000
CHEMICAL NAME :
Isonicotinamide
CAS REGISTRY NUMBER :
1453-82-3
BEILSTEIN REFERENCE NO. :
0002173
LAST UPDATED :
199701
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C6-H6-N2-O
MOLECULAR WEIGHT :
122.14
WISWESSER LINE NOTATION :
T6NJ DVZ
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
MUTATION DATA
TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Rodent - rat Liver
DOSE/DURATION :
20 mmol/L
REFERENCE :
JJIND8 JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. Volume(issue)/page/year: 69,1353,1982
Safety Information
Symbol
GHS07
Signal Word
Warning
Hazard Statements
H315-H319-H335
Precautionary Statements
P261-P305 + P351 + P338
Personal Protective Equipment
dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes
Xi:Irritant
Risk Phrases
R36/37/38
Safety Phrases
S26-S36
RIDADR
NONH for all modes of transport
WGK Germany
3
RTECS
NR9500000
HS Code
29333999
Customs
HS Code
2933399090
Summary
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles29
More Articles
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma.
Br. J. Cancer 111(3) , 477-85, (2014)
Current therapies for metastatic melanoma are targeted either at cancer mutations driving growth (e.g., vemurafenib) or immune-based therapies (e.g., ipilimumab). Tumour progression also requires angi...
[Fe(CN)5(isoniazid)](3-): an iron isoniazid complex with redox behavior implicated in tuberculosis therapy.
J. Inorg. Biochem. 140 , 236-44, (2014)
Tuberculosis has re-emerged as a worldwide threat, which has motivated the development of new drugs. The antituberculosis complex Na3[Fe(CN)5(isoniazid)] (IQG607) in particular is of interest on accou...
Measuring induction times and crystal nucleation rates.
Faraday Discuss. 179 , 199-214, (2015)
A large variation is observed in induction times measured under equal conditions in 1 ml solutions. Ruling out experimental errors, this variation originates from the nucleation process. The induction...